Work

Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels

Year: 2008

Type: article

Source: International Journal of Cancer

DOI: 10.1002/ijc.23626

Authors: Michael Stanglmaier, Margot Faltin, Peter Ruf, Annette Bodenhausen, Petra Schröder, Horst Lindhofer

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2040558969

FWCI: 2.69

Cites: 49

Cited by: 65

Related to: 10